Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
VERITAC-2: Vepdegestrant showed improved progression free survival in metastatic breast cancer with ESR1 mutation 🧬
As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25
#bcsm
Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25
⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects
#bcsm @oncoalert.bsky.social
Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.
Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
Congratulations! You have made an impact on so many people including me!
Fantastic chapter on digital media highlighting benefits and pitfalls of tools like social media and AI
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer
And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Thank you for highlighting our 📕chapter on sexual health! @ascocancer.bsky.social @lizoriordan.bsky.social
This 👇🏾 is for every #oncology clinician who treats #AYA.
Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al
#AYACSM #sexualhealth #lateandlongterm
Hear, HEAR!
#AYACSM #lateandlongterm #cancer #sexualhealth
#supponc #pallonc @pallonccop.bsky.social #survonc
Excited to share that our ASCO Educational Book chapter on sexual health after cancer is now published! Grateful for the opportunity to highlight this vital, often overlooked part of survivorship care.
#CancerSurvivorship #SexualHealth
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy:
A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.
Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social
